| human | Q5 |
| P496 | ORCID iD | 0000-0003-3073-7284 |
| P735 | given name | Tanja | Q12338797 |
| Tanja | Q12338797 | ||
| P106 | occupation | researcher | Q1650915 |
| P5008 | on focus list of Wikimedia project | WikiProject COVID-19 | Q87748614 |
| Q91182855 | 2018 update of the EULAR recommendations for the management of hand osteoarthritis |
| Q93214180 | 2019 EULAR points to consider for non-physician health professionals to prevent and manage fragility fractures in adults 50 years or older |
| Q104564082 | 2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice |
| Q24817087 | Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score |
| Q64074882 | An intergenerational program based on psycho-motor activity promotes well-being and interaction between preschool children and older adults: results of a process and outcome evaluation study in Austria |
| Q97068938 | Changing the outcome measures, changing the results? The urgent need of a specific disease activity score to adult-onset Still's disease |
| Q92628130 | Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendations |
| Q101453775 | Danish translation and validation of the Occupational Balance Questionnaire |
| Q96693284 | Development of classification criteria for hand osteoarthritis: comparative analyses of persons with and without hand osteoarthritis |
| Q91327000 | EULAR 'points to consider' for the conduction of workforce requirement studies in rheumatology |
| Q92962205 | EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases |
| Q96171120 | EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2 |
| Q40305889 | EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update |
| Q98890028 | EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries |
| Q43283606 | Estimation of a numerical value for joint damage-related physical disability in rheumatoid arthritis clinical trials |
| Q38492012 | Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update |
| Q58560039 | Functional consultation and exercises improve grip strength in osteoarthritis of the hand - a randomised controlled trial |
| Q91313847 | I Would Never Take Preventive Medication! Perspectives and Information Needs of People Who Underwent Predictive Tests for Rheumatoid Arthritis |
| Q57809218 | I do not want to suppress the natural process of inflammation: new insights on factors associated with non-adherence in rheumatoid arthritis |
| Q101409567 | Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries |
| Q54957848 | Initial validation and results of the Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: a EULAR project. |
| Q81377241 | Mapping hand functioning in hand osteoarthritis: comparing self-report instruments with a comprehensive hand function test |
| Q34896997 | Methotrexate in rheumatoid arthritis is frequently effective, even if re-employed after a previous failure |
| Q90117045 | Prevention and management of osteoporotic fractures by non-physician health professionals: a systematic literature review to inform EULAR points to consider |
| Q101452622 | Prevention, screening, assessing and managing of non-adherent behaviour in people with rheumatic and musculoskeletal diseases: systematic reviews informing the 2020 EULAR points to consider |
| Q114591800 | Quality Criteria for Real-world Data in Pharmaceutical Research and Health Care Decision-making: Austrian Expert Consensus |
| Q92185175 | Rasch model of the child perceptions questionnaire in multi-country data |
| Q91002575 | Regional and gender differences in population-based oral health insurance data |
| Q35742193 | Reliability of patient-reported outcomes in rheumatoid arthritis patients: an observational prospective study |
| Q33222832 | Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states |
| Q36392370 | Remission by composite scores in rheumatoid arthritis: are ankles and feet important? |
| Q94571464 | Reply to the letter entitled "Rheumatology is exiting the age of "can we" (we certainly can)" by Dr. Bruce Rothschild |
| Q36759845 | Research in hand osteoarthritis: time for reappraisal and demand for new strategies. An opinion paper |
| Q100315322 | Response to: 'Correspondence on 'Changing the outcome measures, changing the results? The urgent need of a specific disease activity score to adult-onset Still's disease'' by Muraviov and Muraviova |
| Q96608925 | Response to: 'Understanding bone fragility: theoretical explanation to non-physician health professionals' by Sugiyama |
| Q44221782 | Rheumatoid arthritis and falls: the influence of disease activity |
| Q89554635 | Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal? |
| Q35953245 | The public neglect of rheumatic diseases: insights from analyses of attendees in a musculoskeletal disease awareness activity |
| Q91553766 | Towards a nationwide implementation of a standardized nutrition and dietetics terminology in clinical practice: a pre-implementation focus group study including a pretest and using the consolidated framework for implementation research |
| Q38690324 | Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force |
| Q38476881 | Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force |
| Q90155757 | Treatment Effects of Bisphosphonates and Denosumab on Survival and Refracture from Real-World Data of Hip-Fractured Patients |
| Q36245728 | Value of self-performed joint counts in rheumatoid arthritis patients near remission |
Search more.